Skip to main content
Clinical Trials/EUCTR2004-002053-31-GB
EUCTR2004-002053-31-GB
Active, not recruiting
Not Applicable

To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancy

Hammersmith Hospital0 sites100 target enrollmentJune 13, 2005
DrugsSinerem

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Hammersmith Hospital
Enrollment
100
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2005
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults patients with gynecological malignancy
  • 2\. Patients who have provided informed cosent
  • 3\. Effective contraception, menopause or surgical sterilisation must be confrimed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Patients allergic to dextran or iron salts
  • 2\. Patients involved in other trials including a molecule under development
  • 3\. Female patients who are breast feeding
  • 4\. Contra\-indication to MRI

Outcomes

Primary Outcomes

Not specified

Similar Trials